Arlesheim, Switzerland

Jean-Pierre Sachetto

USPTO Granted Patents = 10 



Average Co-Inventor Count = 2.4

ph-index = 8

Forward Citations = 628(Granted Patents)


Location History:

  • Riehen, CH (1990)
  • CH-4144, Arlesheim, CH (2008)
  • Arlesheim, CH (1992 - 2015)

Company Filing History:


Years Active: 1990-2015

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Jean-Pierre Sachetto

Introduction

Jean-Pierre Sachetto is a notable inventor based in Arlesheim, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of gelatin capsules. With a total of 10 patents, Sachetto's work has had a considerable impact on the industry.

Latest Patents

One of Sachetto's latest patents involves a Type A gelatin capsule containing polyunsaturated fatty acids (PUFA) in free acid form. This pharmaceutical formulation includes at least one omega-3 polyunsaturated fatty acid in free acid form or a pharmacologically acceptable derivative. The soft gelatin capsule is characterized by gelatin extracted through an acid pre-treatment process of a collagen source. An advantage of this invention is that it does not harden significantly over time, thus providing a longer shelf life compared to similar formulations that use alkali pre-treatment.

Career Highlights

Throughout his career, Sachetto has worked with prominent companies such as Warner-Lambert Company and Tillotts Pharma AG. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and innovations.

Collaborations

Sachetto has collaborated with notable individuals in his field, including Roly Bufton and Thomas Buser. These partnerships have likely enhanced his research and development efforts.

Conclusion

Jean-Pierre Sachetto's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective pharmaceutical formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…